These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 35562628)

  • 1. COVID-19 and corticosteroids: a narrative review.
    El-Saber Batiha G; Al-Gareeb AI; Saad HM; Al-Kuraishy HM
    Inflammopharmacology; 2022 Aug; 30(4):1189-1205. PubMed ID: 35562628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Review of the Evidence for Corticosteroids in COVID-19.
    Johns M; George S; Taburyanskaya M; Poon YK
    J Pharm Pract; 2022 Aug; 35(4):626-637. PubMed ID: 33719698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticosteroid administration for viral pneumonia: COVID-19 and beyond.
    Yang JW; Yang L; Luo RG; Xu JF
    Clin Microbiol Infect; 2020 Sep; 26(9):1171-1177. PubMed ID: 32603802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticosteroid therapy for coronavirus disease 2019-related acute respiratory distress syndrome: a cohort study with propensity score analysis.
    Wu C; Hou D; Du C; Cai Y; Zheng J; Xu J; Chen X; Chen C; Hu X; Zhang Y; Song J; Wang L; Chao YC; Feng Y; Xiong W; Chen D; Zhong M; Hu J; Jiang J; Bai C; Zhou X; Xu J; Song Y; Gong F
    Crit Care; 2020 Nov; 24(1):643. PubMed ID: 33172477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis.
    Ye Z; Wang Y; Colunga-Lozano LE; Prasad M; Tangamornsuksan W; Rochwerg B; Yao L; Motaghi S; Couban RJ; Ghadimi M; Bala MM; Gomaa H; Fang F; Xiao Y; Guyatt GH
    CMAJ; 2020 Jul; 192(27):E756-E767. PubMed ID: 32409522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticosteroid use in viral pneumonia: experience so far and the dexamethasone breakthrough in coronavirus disease-2019.
    Rafiullah M; Siddiqui K
    J Comp Eff Res; 2020 Dec; 9(18):1247-1254. PubMed ID: 33245242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticosteroid treatment in severe COVID-19 patients with acute respiratory distress syndrome.
    Liu J; Zhang S; Dong X; Li Z; Xu Q; Feng H; Cai J; Huang S; Guo J; Zhang L; Chen Y; Zhu W; Du H; Liu Y; Wang T; Chen L; Wen Z; Annane D; Qu J; Chen D
    J Clin Invest; 2020 Dec; 130(12):6417-6428. PubMed ID: 33141117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic corticosteroids for management of COVID-19: Saving lives or causing harm?
    FakhriRavari A; Jin S; Kachouei FH; Le D; Lopez M
    Int J Immunopathol Pharmacol; 2021; 35():20587384211063976. PubMed ID: 34923856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticosteroids and the hyper-inflammatory phase of the COVID-19 disease.
    Taboada M; Caruezo V; Naveira A; Atanassoff PG
    J Clin Anesth; 2020 Nov; 66():109926. PubMed ID: 32474331
    [No Abstract]   [Full Text] [Related]  

  • 10. Corticosteroid use in ARDS and its application to evolving therapeutics for coronavirus disease 2019 (COVID-19): A systematic review.
    Landolf KM; Lemieux SM; Rose C; Johnston JP; Adams CD; Altshuler J; Berger K; Dixit D; Effendi MK; Heavner MS; Lemieux D; Littlefield AJ; Nei AM; Owusu KA; Rinehart M; Robbins B; Rouse GE; Thompson Bastin ML
    Pharmacotherapy; 2022 Jan; 42(1):71-90. PubMed ID: 34662448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticosteroids, COVID-19 pneumonia, and acute respiratory distress syndrome.
    Matthay MA; Wick KD
    J Clin Invest; 2020 Dec; 130(12):6218-6221. PubMed ID: 32976118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis.
    Li H; Chen C; Hu F; Wang J; Zhao Q; Gale RP; Liang Y
    Leukemia; 2020 Jun; 34(6):1503-1511. PubMed ID: 32372026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis.
    Hasan SS; Capstick T; Ahmed R; Kow CS; Mazhar F; Merchant HA; Zaidi STR
    Expert Rev Respir Med; 2020 Nov; 14(11):1149-1163. PubMed ID: 32734777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic steroids in patients with COVID-19: pros and contras, an endocrinological point of view.
    Berton AM; Prencipe N; Giordano R; Ghigo E; Grottoli S
    J Endocrinol Invest; 2021 Apr; 44(4):873-875. PubMed ID: 32514902
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study.
    Bartoletti M; Marconi L; Scudeller L; Pancaldi L; Tedeschi S; Giannella M; Rinaldi M; Bussini L; Valentini I; Ferravante AF; Potalivo A; Marchionni E; Fornaro G; Pascale R; Pasquini Z; Puoti M; Merli M; Barchiesi F; Volpato F; Rubin A; Saracino A; Tonetti T; Gaibani P; Ranieri VM; Viale P; Cristini F;
    Clin Microbiol Infect; 2021 Jan; 27(1):105-111. PubMed ID: 32971254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia.
    Zhou W; Liu Y; Tian D; Wang C; Wang S; Cheng J; Hu M; Fang M; Gao Y
    Signal Transduct Target Ther; 2020 Feb; 5(1):18. PubMed ID: 32296012
    [No Abstract]   [Full Text] [Related]  

  • 17. Nitazoxanide and COVID-19: A review.
    Al-Kuraishy HM; Al-Gareeb AI; Elekhnawy E; Batiha GE
    Mol Biol Rep; 2022 Nov; 49(11):11169-11176. PubMed ID: 36094778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of EARLY administration of DEXamethasone in patients with COVID-19 pneumonia without acute hypoxemic respiratory failure and risk of development of acute respiratory distress syndrome (EARLY-DEX COVID-19): study protocol for a randomized controlled trial.
    Franco-Moreno A; Acedo-Gutiérrez MS; Martín NL; Hernández-Blanco C; Rodríguez-Olleros C; Ibáñez-Estéllez F; Suárez-Simón A; Balado-Rico M; Romero-Paternina AR; Alonso-Menchén D; Escolano-Fernández B; Piniella-Ruiz E; Alonso-Monge E; Notario-Leo H; Bibiano-Guillén C; Peña-Lillo G; Antiqueira-Pérez A; Romero-Pareja R; Cabello-Clotet N; Estrada-Pérez V; Troya-García J; de Carranza-López M; Escobar-Rodríguez I; Vallejo-Maroto N; Torres-Macho J
    Trials; 2022 Sep; 23(1):784. PubMed ID: 36109825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of pulse-dose and high-dose corticosteroids with no corticosteroid treatment for COVID-19 pneumonia in the intensive care unit.
    Yaqoob H; Greenberg D; Hwang F; Lee C; Vernik D; Manglani R; Wang Z; Murad MH; Chandy D; Epelbaum O
    J Med Virol; 2022 Jan; 94(1):349-356. PubMed ID: 34542192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A global treatments for coronaviruses including COVID-19.
    Yousefi B; Valizadeh S; Ghaffari H; Vahedi A; Karbalaei M; Eslami M
    J Cell Physiol; 2020 Dec; 235(12):9133-9142. PubMed ID: 32394467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.